Fingerprint Dive into the research topics of 'Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy trial (ORIENT): Rationale and study design'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Olmesartan Reducing Incidence of Endstage Renal Disease in Diabetic Nephropathy trial (ORIENT): Rationale and study design
Enyu Imai, Sadayoshi Ito, Masakazu Haneda, Juliana C.N. Chan, Hirofumi Makino
Research output: Contribution to journal › Article › peer-review
40
Citations
(Scopus)